Masked hypertension is a condition where an individual's blood pressure (BP) measurements are normal in a clinical setting, such as a doctor's office or hospital, but are elevated when measured outside of a clinical setting. This means that the person's BP remains consistently high during their daily activities and at home, despite appearing normotensive in medical settings.

Masked hypertension is often undetected and untreated due to its "masked" nature, which can lead to an increased risk of developing cardiovascular diseases over time. Proper diagnosis typically requires ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) for a more accurate assessment of a person's true BP patterns and levels.

White coat hypertension (WCH) is a phenomenon where a patient's blood pressure (BP) is persistently higher in a clinical setting, such as a doctor's office or hospital, compared to measurements taken in other settings. This increase in BP is often attributed to the anxiety or stress experienced by the patient due to the medical environment and the presence of healthcare providers, particularly when wearing a white coat.

To medically define WCH, the following criteria are generally used:

1. The office or clinical blood pressure readings are ≥ 140 mmHg systolic and/or ≥ 90 mmHg diastolic on at least two separate occasions.
2. Out-of-office blood pressure readings, such as home measurements or 24-hour ambulatory blood pressure monitoring (ABPM), are consistently normal (< 135 mmHg systolic and < 85 mmHg diastolic).

It is essential to distinguish white coat hypertension from sustained hypertension, as the latter requires appropriate treatment. While WCH itself is not considered a disease, it may indicate an increased risk of developing essential hypertension in the future. Regular out-of-office blood pressure monitoring and lifestyle modifications are often recommended for patients with white coat hypertension to help manage their cardiovascular health.

Ambulatory Blood Pressure Monitoring (ABPM) is a non-invasive method of measuring blood pressure at regular intervals over a 24-hour period or more. This is typically done using a portable device that is worn on a belt around the waist and connected to a cuff wrapped around the upper arm. The device automatically inflates the cuff and records blood pressure readings at preset intervals, usually every 15 to 30 minutes during the day and every 30 to 60 minutes during the night.

ABPM provides valuable information about blood pressure patterns over an extended period, including how it varies throughout the day and in response to daily activities, posture changes, and sleep. This can help healthcare providers diagnose and manage hypertension more effectively, as well as assess the effectiveness of antihypertensive medications. ABPM is also useful for identifying white coat hypertension, a condition where blood pressure readings are higher in a medical setting than in daily life.

Overall, ambulatory blood pressure monitoring is an important tool in the diagnosis and management of hypertension and related cardiovascular diseases.

Hypertension is a medical term used to describe abnormally high blood pressure in the arteries, often defined as consistently having systolic blood pressure (the top number in a blood pressure reading) over 130 mmHg and/or diastolic blood pressure (the bottom number) over 80 mmHg. It is also commonly referred to as high blood pressure.

Hypertension can be classified into two types: primary or essential hypertension, which has no identifiable cause and accounts for about 95% of cases, and secondary hypertension, which is caused by underlying medical conditions such as kidney disease, hormonal disorders, or use of certain medications.

If left untreated, hypertension can lead to serious health complications such as heart attack, stroke, heart failure, and chronic kidney disease. Therefore, it is important for individuals with hypertension to manage their condition through lifestyle modifications (such as healthy diet, regular exercise, stress management) and medication if necessary, under the guidance of a healthcare professional.

Prehypertension is a term used to describe blood pressure levels that are higher than normal but not yet high enough to be classified as hypertension or stage 1 high blood pressure. It is often considered a warning sign or a state of increased risk for developing full-blown hypertension and its associated complications, such as heart disease and stroke.

According to the American Heart Association (AHA), prehypertension is defined by systolic blood pressure (SBP) levels ranging from 120 to 139 mmHg or diastolic blood pressure (DBP) levels ranging from 80 to 89 mmHg. It's important to note that individuals with prehypertension should take steps to lower their blood pressure through lifestyle modifications, such as maintaining a healthy weight, engaging in regular physical activity, following a balanced diet, and limiting alcohol consumption and sodium intake. In some cases, medication may also be recommended to help manage blood pressure levels.

In the context of medical terminology, "office visits" refer to patients' appointments or consultations with healthcare professionals in their respective offices or clinics. These visits may include various services such as physical examinations, diagnosis, treatment planning, prescribing medications, providing referrals, and offering counseling or education on health-related topics. Office visits can be for routine checkups, follow-up appointments, or addressing acute or chronic medical concerns. It is important to note that office visits do not include services provided in a hospital setting, emergency department, or other healthcare facilities.

Blood pressure determination is the medical procedure to measure and assess the force or pressure exerted by the blood on the walls of the arteries during a heartbeat cycle. It is typically measured in millimeters of mercury (mmHg) and is expressed as two numbers: systolic pressure (the higher number, representing the pressure when the heart beats and pushes blood out into the arteries) and diastolic pressure (the lower number, representing the pressure when the heart rests between beats). A normal blood pressure reading is typically around 120/80 mmHg. High blood pressure (hypertension) is defined as a consistently elevated blood pressure of 130/80 mmHg or higher, while low blood pressure (hypotension) is defined as a consistently low blood pressure below 90/60 mmHg. Blood pressure determination is an important vital sign and helps to evaluate overall cardiovascular health and identify potential health risks.

Blood pressure is the force exerted by circulating blood on the walls of the blood vessels. It is measured in millimeters of mercury (mmHg) and is given as two figures:

1. Systolic pressure: This is the pressure when the heart pushes blood out into the arteries.
2. Diastolic pressure: This is the pressure when the heart rests between beats, allowing it to fill with blood.

Normal blood pressure for adults is typically around 120/80 mmHg, although this can vary slightly depending on age, sex, and other factors. High blood pressure (hypertension) is generally considered to be a reading of 130/80 mmHg or higher, while low blood pressure (hypotension) is usually defined as a reading below 90/60 mmHg. It's important to note that blood pressure can fluctuate throughout the day and may be affected by factors such as stress, physical activity, and medication use.

Pulmonary hypertension is a medical condition characterized by increased blood pressure in the pulmonary arteries, which are the blood vessels that carry blood from the right side of the heart to the lungs. This results in higher than normal pressures in the pulmonary circulation and can lead to various symptoms and complications.

Pulmonary hypertension is typically defined as a mean pulmonary artery pressure (mPAP) greater than or equal to 25 mmHg at rest, as measured by right heart catheterization. The World Health Organization (WHO) classifies pulmonary hypertension into five groups based on the underlying cause:

1. Pulmonary arterial hypertension (PAH): This group includes idiopathic PAH, heritable PAH, drug-induced PAH, and associated PAH due to conditions such as connective tissue diseases, HIV infection, portal hypertension, congenital heart disease, and schistosomiasis.
2. Pulmonary hypertension due to left heart disease: This group includes conditions that cause elevated left atrial pressure, such as left ventricular systolic or diastolic dysfunction, valvular heart disease, and congenital cardiovascular shunts.
3. Pulmonary hypertension due to lung diseases and/or hypoxia: This group includes chronic obstructive pulmonary disease (COPD), interstitial lung disease, sleep-disordered breathing, alveolar hypoventilation disorders, and high altitude exposure.
4. Chronic thromboembolic pulmonary hypertension (CTEPH): This group includes persistent obstruction of the pulmonary arteries due to organized thrombi or emboli.
5. Pulmonary hypertension with unclear and/or multifactorial mechanisms: This group includes hematologic disorders, systemic disorders, metabolic disorders, and other conditions that can cause pulmonary hypertension but do not fit into the previous groups.

Symptoms of pulmonary hypertension may include shortness of breath, fatigue, chest pain, lightheadedness, and syncope (fainting). Diagnosis typically involves a combination of medical history, physical examination, imaging studies, and invasive testing such as right heart catheterization. Treatment depends on the underlying cause but may include medications, oxygen therapy, pulmonary rehabilitation, and, in some cases, surgical intervention.

Antihypertensive agents are a class of medications used to treat high blood pressure (hypertension). They work by reducing the force and rate of heart contractions, dilating blood vessels, or altering neurohormonal activation to lower blood pressure. Examples include diuretics, beta blockers, ACE inhibitors, ARBs, calcium channel blockers, and direct vasodilators. These medications may be used alone or in combination to achieve optimal blood pressure control.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Left ventricular hypertrophy (LVH) is a medical condition in which the left ventricle of the heart undergoes an enlargement or thickening of its muscle wall. The left ventricle is the main pumping chamber of the heart that supplies oxygenated blood to the rest of the body.

In response to increased workload, such as hypertension (high blood pressure), aortic valve stenosis, or athletic training, the left ventricular muscle may thicken and enlarge. This process is called "hypertrophy." While some degree of hypertrophy can be adaptive in athletes, significant or excessive hypertrophy can lead to impaired relaxation and filling of the left ventricle during diastole, reduced pumping capacity, and decreased compliance of the chamber.

Left ventricular hypertrophy is often asymptomatic initially but can increase the risk of various cardiovascular complications such as heart failure, arrhythmias, myocardial infarction (heart attack), and sudden cardiac death over time. It is typically diagnosed through imaging techniques like echocardiography or cardiac MRI and confirmed by measuring the thickness of the left ventricular wall.

Renal hypertension, also known as renovascular hypertension, is a type of secondary hypertension (high blood pressure) that is caused by narrowing or obstruction of the renal arteries or veins, which supply blood to the kidneys. This can lead to decreased blood flow and oxygen delivery to the kidney tissue, activating the renin-angiotensin-aldosterone system (RAAS) and resulting in increased peripheral vascular resistance, sodium retention, and extracellular fluid volume, ultimately causing hypertension.

Renal hypertension can be classified into two types:

1. Renin-dependent renal hypertension: This is caused by a decrease in blood flow to the kidneys, leading to increased renin release from the juxtaglomerular cells of the kidney. Renin converts angiotensinogen to angiotensin I, which is then converted to angiotensin II by angiotensin-converting enzyme (ACE). Angiotensin II is a potent vasoconstrictor that causes an increase in peripheral vascular resistance and blood pressure.
2. Renin-independent renal hypertension: This is caused by increased sodium retention and extracellular fluid volume, leading to an increase in blood pressure. This can be due to various factors such as obstructive sleep apnea, primary aldosteronism, or pheochromocytoma.

Renal hypertension is often asymptomatic but can lead to serious complications such as kidney damage, heart failure, and stroke if left untreated. Diagnosis of renal hypertension involves imaging studies such as renal artery duplex ultrasound, CT angiography, or magnetic resonance angiography (MRA) to identify any narrowing or obstruction in the renal arteries or veins. Treatment options include medications such as ACE inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, and diuretics, as well as interventions such as angioplasty and stenting to improve blood flow to the kidneys.

Portal hypertension is a medical condition characterized by an increased pressure in the portal vein, which is the large blood vessel that carries blood from the intestines, spleen, and pancreas to the liver. Normal portal venous pressure is approximately 5-10 mmHg. Portal hypertension is defined as a portal venous pressure greater than 10 mmHg.

The most common cause of portal hypertension is cirrhosis of the liver, which leads to scarring and narrowing of the small blood vessels in the liver, resulting in increased resistance to blood flow. Other causes include blood clots in the portal vein, inflammation of the liver or bile ducts, and invasive tumors that block the flow of blood through the liver.

Portal hypertension can lead to a number of complications, including the development of abnormal blood vessels (varices) in the esophagus, stomach, and intestines, which are prone to bleeding. Ascites, or the accumulation of fluid in the abdominal cavity, is another common complication of portal hypertension. Other potential complications include encephalopathy, which is a condition characterized by confusion, disorientation, and other neurological symptoms, and an increased risk of bacterial infections.

Treatment of portal hypertension depends on the underlying cause and the severity of the condition. Medications to reduce pressure in the portal vein, such as beta blockers or nitrates, may be used. Endoscopic procedures to band or inject varices can help prevent bleeding. In severe cases, surgery or liver transplantation may be necessary.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

Renovascular hypertension is a type of secondary hypertension (high blood pressure) that is caused by renal artery stenosis or narrowing. This condition reduces blood flow to the kidneys, leading to the activation of the renin-angiotensin-aldosterone system (RAAS), which causes an increase in peripheral vascular resistance and blood volume, resulting in hypertension.

Renovascular hypertension is often seen in people with atherosclerosis or fibromuscular dysplasia, which are the most common causes of renal artery stenosis. Other conditions that can lead to renovascular hypertension include vasculitis, blood clots, and compression of the renal artery by nearby structures.

Diagnosis of renovascular hypertension typically involves imaging studies such as duplex ultrasound, CT angiography, or magnetic resonance angiography to visualize the renal arteries and assess for stenosis. Treatment may involve medications to control blood pressure, lifestyle modifications, and procedures such as angioplasty and stenting to open up the narrowed renal artery. In some cases, surgery may be necessary to restore blood flow to the kidney.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Malignant hypertension is a severe form of hypertension (high blood pressure) that is characterized by extremely high blood pressure readings, typically greater than 180/120 mmHg, along with evidence of damage to one or more organ systems. This condition is considered a medical emergency and requires immediate treatment.

Malignant hypertension can cause rapid and severe damage to various organs in the body, including the brain, heart, kidneys, and eyes. Symptoms may include severe headache, visual disturbances, confusion, shortness of breath, chest pain, nausea, vomiting, seizures, and even coma.

The exact cause of malignant hypertension is not always known, but it can be associated with certain underlying medical conditions such as kidney disease, autoimmune disorders, pregnancy-related complications, or the use of certain medications. Treatment typically involves aggressive blood pressure control using intravenous medications in a hospital setting, along with management of any underlying conditions and prevention of further organ damage.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.